Skip to main content
logo
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.530
-0.070 (-4.38%)
At close: Apr 23, 2026, 4:00 PM EDT
1.530
0.00 (0.00%)
Pre-market: Apr 24, 2026, 4:22 AM EDT

Autolus Therapeutics Revenue

In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 644.94% growth. Autolus Therapeutics had revenue of $24.29M in the quarter ending December 31, 2025, with 83,655.17% growth.

Revenue (ttm)
$75.39M
Revenue Growth
+644.94%
P/S Ratio
5.40
Revenue / Employee
$99,984
Employees
754
Market Cap
407.20M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202575.39M65.27M644.94%
Dec 31, 202410.12M8.42M496.00%
Dec 31, 20231.70M-4.66M-73.30%
Dec 31, 20226.36M4.03M172.96%
Dec 31, 20212.33M615.00K35.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Century Therapeutics109.16M
Lineage Cell Therapeutics14.56M
Prelude Therapeutics12.14M
PureTech Health6.39M
Neurogene925.00K
Revenue Rankings

AUTL News

More News